Related Experiment Video
Updated: May 17, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Emerging noninvasive biomarkers for early detection of Alzheimer's disease
Leonardo Guzmán-Martínez1, Gonzalo A Farías, Ricardo B Maccioni
1Laboratory of Cellular and Molecular Neurosciences, Faculty of Science, University of Chile, Santiago, Chile. lguzmar@gmail.com
Abstract:
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsychological testing. The development of accurate, easy to use and inexpensive biological markers for AD is a long-standing aspiration for researchers and the medical community. Here we describe some of the recent advances in the field of biomarkers, both in cerebrospinal fluid (CSF) and in peripheral blood.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer's Disease: Treatment
Alzheimer Disease ll: Pathophysiology